Evidence map›Paper›PMID 39392586›Full record

Observational studyInfection2025

Epidemiological changes and outcomes of people living with HIV admitted to the intensive care unit: a 14-year retrospective study.

Esther Martínez, Alberto Foncillas, Adrián Téllez, Sara Fernández, Gemma Martínez-Nadal, Verónica Rico, Adrià Tomé, Ainoa Ugarte, Mariano Rinaudo, Leire Berrocal and 6 more

Abstract readObservational Study
In one paragraph

Observational study in Infection, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Esther MartínezIntensive Care Unit, Hospital General de Granollers, Granollers, Spain.
Alberto FoncillasInfectious Diseases Department, Hospital Clínic, Barcelona, Spain.
Adrián TéllezMedical Intensive Care Unit, Hospital Clínic, Barcelona, Spain.
Sara FernándezMedical Intensive Care Unit, Hospital Clínic, Barcelona, Spain.
Gemma Martínez-NadalMedical Intensive Care Unit, Hospital Clínic, Barcelona, Spain.
Verónica RicoInfectious Diseases Department, Hospital Clínic, Barcelona, Spain.
Adrià ToméMedical Intensive Care Unit, Hospital Clínic, Barcelona, Spain.
Ainoa UgarteInfectious Diseases Department, Hospital Clínic, Barcelona, Spain.
Mariano RinaudoMedical Intensive Care Unit, Hospital Clínic, Barcelona, Spain.
Leire BerrocalInfectious Diseases Department, Hospital Clínic, Barcelona, Spain.
Elisa De LazzariUniversity of Barcelona, Barcelona, Spain.
Jose M MiróUniversity of Barcelona, Barcelona, Spain.
Jose M NicolásUniversity of Barcelona, Barcelona, Spain.
Josep MallolasUniversity of Barcelona, Barcelona, Spain.
Lorena De la Mora *Infectious Diseases Department, Hospital Clínic, Barcelona, Spain.
Pedro Castro *University of Barcelona, Barcelona, Spain. pcastro@clinic.cat.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposesSince 2016, the World Health Organization has recommended universal antiretroviral therapy (ART) for all people living with Human Immunodeficiency Virus (PLHIV). This recommendation may have influenced the characteristics and outcomes of PLHIV admitted to the Intensive Care Unit (ICU). This study aims to identify changes in the epidemiological and clinical characteristics of PLHIV admitted to the ICU, and their short- and medium-term outcomes before and after the implementation of universal ART (periods 2006-2015 and 2016-2019).

methodsThis retrospective, observational, single-center study included all adult PLHIV admitted to the ICU of a University Hospital in Barcelona from 2006 to 2019.

resultsThe study included 502 admissions involving 428 patients, predominantly men (75%) with a median (P25-P75) age of 47.5 years (39.7-53.9). Ninety-one percent were diagnosed with HIV before admission, with 82% under ART and 60% admitted from the emergency department. In 2016-2019, there were more patients on ART pre-admission, reduced needs for invasive mechanical ventilation (IMV) and fewer in-ICU complications. ICU mortality was also lower (14% vs 7%). Predictors of in-ICU mortality included acquired immunodeficiency syndrome defining event (ADE)-related admissions, ICU complications, higher SOFA scores, IMV and renal replacement therapy (RRT) requirement. ART use during ICU admission was protective. Higher SOFA scores, admission from hospital wards, and more comorbidities predicted one-year mortality.

conclusionsThe in-ICU mortality of critically ill PLHIV has decreased in recent years, likely due to changes in patient characteristics. Pre- and ICU admission features remain the primary predictors of short- and medium-term outcomes.

Indexed as

HIV InfectionsIntensive Care UnitsAdultFemaleHospitalizationHospital MortalityHumansMaleMiddle AgedRetrospective StudiesSpainAcquired immunodeficiency syndrome (AIDS)Antiretroviral therapy (ART)Critical careHIV infectionHuman immunodeficiency virus (HIV)Intensive care unit (ICU)

Identifiers

PMID39392586
PMCPMC11971213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.